Reproductive hormones regulate the selective permeability of the blood-brain barrier

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 6, 2008, Pages 401-407

  Wilson, Andrea C ^a   Clemente, Luca ^a   Liu, Tianbing ^a   Bowen, Richard L ^b   Meethal, Sivan Vadakkadath ^a   Atwood, Craig S ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b OTB Research   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Blood brain barrier; Connexin 43; Follicle stimulating hormone; Gap junction; Leuprolide acetate; Luteinizing hormone; Ovariectomy; Receptor; Selective permeability; Sex steroid; Stroke; Tight junction; Zona occludens 1

Indexed keywords

CONNEXIN 43; ESTROGEN; GONADOTROPIN; LEUPRORELIN; PROTEIN ZO1; SEX HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GAP JUNCTION; HORMONE ACTION; MICROVASCULATURE; MOUSE; NONHUMAN; OVARIECTOMY; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SENESCENCE; TIGHT JUNCTION;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD-BRAIN BARRIER; CONNEXIN 43; FEMALE; FOLLICLE STIMULATING HORMONE; GAP JUNCTIONS; GONADAL STEROID HORMONES; GONADOTROPINS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LEUPROLIDE; LUTEINIZING HORMONE; MICE; MICE, INBRED STRAINS; OVARIECTOMY; PERMEABILITY; TIGHT JUNCTIONS;

ANIMALIA; MUS;

EID: 43549115447     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.02.011     Document Type: Article

References (73)

1. Elrich P. Das Sauerstoffbeduerfnis des organismus: Einus farbenanalytiche studie 8 (1885) 167
2. Nagasawa K., Chiba H., Fujita H., Kojima T., Saito T., Endo T., and Sawada N. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells. J. Cell Physiol. 208 (2006) 123-132
3. Nakase T., and Naus C.C. Gap junctions and neurological disorders of the central nervous system. Biochim. Biophys. Acta 1662 (2004) 149-158
4. Aspinall R. Age-related changes in the function of T cells. Microsc. Res. Tech. 62 (2003) 508-513
5. Scholz W. Studien zur Pathologic der Hirngef~ 13e IL Die drusige Entartung der Hirnarterien und -capillaren. Z. Ges. Neurol. Psychiatr. 162 (1938) 694-7159
6. Kalaria R.N. Cerebral vessels in ageing and Alzheimer's disease. Pharmacol. Ther. 72 (1996) 193-214
7. Deane R., and Zlokovic B.V. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr. Alzheimer. Res. 4 (2007) 191-197
8. Matsumoto Y., Yanase D., Noguchi-Shinohara M., Ono K., Yoshita M., and Yamada M. Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 23 (2007) 241-245
9. Zipser B.D., Johanson C.E., Gonzalez L., Berzin T.M., Tavares R., Hulette C.M., Vitek M.P., Hovanesian V., and Stopa E.G. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol. Aging 28 (2007) 977-986
10. Stewart P.A., Hayakawa K., Farrell C.L., and Del Maestro R.F. Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect. J. Neurosurg. 67 (1987) 697-705
11. Atwood C.S., Bowen R.L., Smith M.A., and Perry G. Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply. Brain Res. Brain Res. Rev. 43 (2003) 164-178
12. Fiala M., Liu Q.N., Sayre J., Pop V., Brahmandam V., Graves M.C., and Vinters H.V. Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. Eur. J. Clin. Invest. 32 (2002) 360-371
13. Bake S., and Sohrabji F. 17beta-estradiol differentially regulates blood-brain barrier permeability in young and aging female rats. Endocrinology 145 (2004) 5471-5475
14. Wiesen J.F., and Midgley Jr. A.R. Changes in expression of connexin 43 gap junction messenger ribonucleic acid and protein during ovarian follicular growth. Endocrinology 133 (1993) 741-746
15. Granot I., and Dekel N. Phosphorylation and expression of connexin-43 ovarian gap junction protein are regulated by luteinizing hormone. J. Biol. Chem. 269 (1994) 30502-30509
16. Granot I., and Dekel N. Developmental expression and regulation of the gap junction protein and transcript in rat ovaries. Mol. Reprod. Dev. 47 (1997) 231-239
17. Wehrenberg U., and Rune G.M. Spontaneous luteinization of antral marmoset follicles in vitro. Mol. Hum. Reprod. 6 (2000) 504-509
18. Kalma Y., Granot I., Galiani D., Barash A., and Dekel N. Luteinizing hormone-induced connexin 43 down-regulation: inhibition of translation. Endocrinology 145 (2004) 1617-1624
19. Ambrus G., and Rao C.V. Novel regulation of pregnant human myometrial smooth muscle cell gap junctions by human chorionic gonadotropin. Endocrinology 135 (1994) 2772-2779
20. Granot I., Dekel N., Bechor E., Segal I., Fieldust S., and Barash A. Temporal analysis of connexin43 protein and gene expression throughout the menstrual cycle in human endometrium. Fertil. Steril. 73 (2000) 381-386
21. Shimada M., and Terada T. FSH and LH induce progesterone production and progesterone receptor synthesis in cumulus cells: a requirement for meiotic resumption in porcine oocytes. Mol. Hum. Reprod. 8 (2002) 612-618
22. Sasson R., and Amsterdam A. Stimulation of apoptosis in human granulosa cells from in vitro fertilization patients and its prevention by dexamethasone: involvement of cell contact and bcl-2 expression. J. Clin. Endocrinol. Metab. 87 (2002) 3441-3451
23. Sela-Abramovich S., Chorev E., Galiani D., and Dekel N. Mitogen-activated protein kinase mediates luteinizing hormone-induced breakdown of communication and oocyte maturation in rat ovarian follicles. Endocrinology 146 (2005) 1236-1244
24. Gulinello M., and Etgen A.M. Sexually dimorphic hormonal regulation of the gap junction protein, CX43, in rats and altered female reproductive function in CX43+/- mice. Brain Res. 1045 (2005) 107-115
25. Ye L., Martin T.A., Parr C., Harrison G.M., Mansel R.E., and Jiang W.G. Biphasic effects of 17-beta-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells. J. Cell Physiol. 196 (2003) 362-369
26. Zeng R., Li X., and Gorodeski G.I. Estrogen abrogates transcervical tight junctional resistance by acceleration of occludin modulation. J. Clin. Endocrinol. Metab. 89 (2004) 5145-5155
27. Regidor P.A., Regidor M., Schindler A.E., and Winterhager E. Aberrant expression pattern of gap junction connexins in endometriotic tissues. Mol. Hum. Reprod. 3 (1997) 375-381
28. Khan-Dawood F.S., Yang J., and Dawood M.Y. Localization and expression of zonula occludens-1 tight junction-associated protein in baboon (Papio anubis) corpora lutea. Hum. Reprod. 11 (1996) 1262-1267
29. Couzinet B., and Schaison G. The control of gonadotrophin secretion by ovarian steroids. Hum. Reprod. Suppl. 2 (1993) 97-101
30. Chakravarti S., Collins W.P., Forecast J.D., Newton J.R., Oram D.H., and Studd J.W. Hormonal profiles after the menopause. Br. Med. J. 2 (1976) 784-787
31. Neaves W.B., Johnson L., Porter J.C., Parker C.R.J., and Petty C.S. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J. Clin. Endocrinol. Metab. 59 (1984) 756-763
32. Toth P., Lukacs H., Gimes G., Sebestyen A., Pasztor N., Paulin F., and Rao C.V. Clinical importance of vascular LH/hCG receptors-a review. Reprod. Biol. 1 (2001) 5-11
33. Berndt S., Perrier d'Hauterive S., Blacher S., Pequeux C., Lorquet S., Munaut C., Applanat M., Herve M.A., Lamande N., Corvol P., van den Brule F., Frankenne F., Poutanen M., Huhtaniemi I., Geenen V., Noel A., and Foidart J.M. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. Faseb. J. 20 (2006) 2630-2632
34. Lei Z.M., Rao C.V., Kornyei J.L., Licht P., and Hiatt E.S. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology 132 (1993) 2262-2270
35. al-Hader A.A., Lei Z.M., and Rao C.V. Neurons from fetal rat brains contain functional luteinizing hormone/chorionic gonadotropin receptors. Biol. Reprod. 56 (1997) 1071-1076
36. al-Hader A.A., Tao Y.X., Lei Z.M., and Rao C.V. Fetal rat brains contain luteinizing hormone/human chorionic gonadotropin receptors. Early Pregnancy 3 (1997) 323-329
37. Bowen R.L., Verdile G., Liu T., Parlow A.F., Perry G., Smith M.A., Martins R.N., and Atwood C.S. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J. Biol. Chem. 279 (2004) 20539-20545
38. Liu T., Wimalasena J., Bowen R.L., and Atwood C.S. Luteinizing hormone receptor mediates neuronal pregnenolone production via up-regulation of steroidogenic acute regulatory protein expression. J. Neurochem. 100 (2007) 1329-1339
39. Bronson F.H. The regulation of luteinizing hormone secretion by estrogen: relationships among negative feedback, surge potential, and male stimulation in juvenile, peripubertal, and adult female mice. Endocrinology 108 (1981) 506-516
40. Naik S.I., Young L.S., Charlton H.M., and Clayton R.N. Pituitary gonadotropin-releasing hormone receptor regulation in mice. II: Females. Endocrinology 115 (1984) 114-120
41. Reese T.S., and Karnovsky M.J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 34 (1967) 207-217
42. Brightman M.W., and Reese T.S. Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell Biol. 40 (1969) 648-677
43. Nagy Z., Peters H., and Huttner I. Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. Lab. Invest. 50 (1984) 313-322
44. Lukacs H., Hiatt E.S., Lei Z.M., and Rao C.V. Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats. Horm. Behav. 29 (1995) 42-58
45. Wilson A.C., Salamat M.S., Haasl R.J., Roche K.M., Karande A., Meethal S.V., Terasawa E., Bowen R.L., and Atwood C.S. Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression. J. Endocrinol. 191 (2006) 651-663
46. Bowen R.L., Smith M.A., Harris P.L., Kubat Z., Martins R.N., Castellani R.J., Perry G., and Atwood C.S. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J. Neurosci. Res. 70 (2002) 514-518
47. Stein D.G., Wright D.W., and Kellermann A.L. Does progesterone have neuroprotective properties?. Ann. Emerg. Med. (2007)
48. Tsukahara S., Maekawa F., Tsukamura H., Hirunagi K., and Maeda K. Morphological characterization of relationship between gap junctions and gonadotropin releasing hormone nerve terminals in the rat median eminence. Neurosci. Lett. 261 (1999) 105-108
49. Gore A.C., and Terasawa E. A study of the hypothalamic pulse-generating mechanism responsible for LH release: electrical stimulation of the medial basal hypothalamus in the ovariectomized guinea pig. Brain Res. 560 (1991) 268-275
50. Gore A.C., Windsor-Engnell B.M., and Terasawa E. Menopausal increases in pulsatile gonadotropin-releasing hormone release in a nonhuman primate (Macaca mulatta). Endocrinology 145 (2004) 4653-4659
51. Chanson P., and Schaison G. Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma. J. Clin. Endocrinol. Metab. 80 (1995) 2267-2268
52. Hernandez Morin N., Huet D., and Hautecouverture M. [Two cases of non-functional gonadotroph adenoma pituitary apoplexy following GnRH-agonist treatment revealing gonadotroph adenoma and pseudopituitary apoplexy after GnRH administration]. Ann. Endocrinol. (Paris). 64 (2003) 227-231
53. Physicians' Desk Reference, 61st ed., Thomson PDR, Montvale 2007.
54. Shirasawa N., Mabuchi Y., Sakuma E., Horiuchi O., Yashiro T., Kikuchi M., Hashimoto Y., Tsuruo Y., Herbert D.C., and Soji T. Intercellular communication within the rat anterior pituitary gland: X. Immunohistocytochemistry of S-100 and connexin 43 of folliculo-stellate cells in the rat anterior pituitary gland. Anat. Rec. A. Discov. Mol. Cell Evol. Biol. 278 (2004) 462-473
55. Brooks T.A., Hawkins B.T., Huber J.D., Egleton R.D., and Davis T.P. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Am. J. Physiol. Heart. Circ. Physiol. 289 (2005) H738-H743
56. Bowen R.L., Isley J.P., and Atkinson R.L. An association of elevated serum gonadotropin concentrations and Alzheimer disease?. J. Neuroendocrinol. 12 (2000) 351-354
57. Short R.A., Bowen R.L., O'Brien P.C., and Graff-Radford N.R. Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin. Proc. 76 (2001) 906-909
58. Nagy J.I., Li W., Hertzberg E.L., and Marotta C.A. Elevated connexin43 immunoreactivity at sites of amyloid plaques in Alzheimer's disease. Brain Res. 717 (1996) 173-178
59. Atwood C.S., Bishop G.M., Perry G., and Smith M.A. Amyloid-beta: a vascular sealant that protects against hemorrhage?. J. Neurosci. Res. 70 (2002) 356
60. Atwood C.S., Perry G., and Smith M.A. Cerebral hemorrhage and amyloid-beta. Science 299 (2003) 1014 author reply 1014
61. Linzell J.L., and Peaker M. Changes in colostrum composition and in the permeability of the mammary epithelium at about the time of parturition in the goat. J. Physiol. 243 (1974) 129-151
62. Peaker M. Recent advances in the study of monovalent ions movements across the mammary epithelium: relation to onset of lactation. J. Dairy Sci. 58 (1975) 1042-1047
63. Pitelka D.R., Hamamoto S.T., Duafala J.G., and Nemanic M.K. Cell contacts in the mouse mammary gland. I. Normal gland in postnatal development and the secretory cycle. J. Cell Biol. 56 (1973) 797-818
64. Stewart P.A., and Hayakawa E.M. Interendothelial junctional changes underlie the developmental 'tightening' of the blood-brain barrier. Brain Res. 429 (1987) 271-281
65. Schulze C., and Firth J.A. Interendothelial junctions during blood-brain barrier development in the rat: morphological changes at the level of individual tight junctional contacts. Brain Res. Dev. Brain Res. 69 (1992) 85-95
66. Kawamura K., Kumagai J., Sudo S., Chun S.Y., Pisarska M., Morita H., Toppari J., Fu P., Wade J.D., Bathgate R.A., and Hsueh A.J. Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7323-7328
67. Atwood C.S., Meethal S.V., Liu T., Wilson A.C., Gallego M., Smith M.A., and Bowen R.L. Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence. J. Neuropathol. Exp. Neurol. 64 (2005) 93-103
68. Zhang Y.X., Xu H.T., Qi F.J., and Wang E.H. [Expression of connexin 43 in lung cancer and its correlation with E-cadherin]. Zhonghua BingLiXue ZaZhi 35 (2006) 339-343
69. Morita T., Mizutani Y., Sawada M., and Shimada A. Immunohistochemical and ultrastructural findings related to the blood-brain barrier in the blood vessels of the cerebral white matter in aged dogs. J. Comp. Pathol. 133 (2005) 14-22
70. Su M.Y., Head E., Brooks W.M., Wang Z., Muggenburg B.A., Adam G.E., Sutherland R., Cotman C.W., and Nalcioglu O. Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging. Neurobiol. Aging 19 (1998) 479-485
71. Shah G.N., and Mooradian A.D. Age-related changes in the blood-brain barrier. Exp. Gerontol. 32 (1997) 501-519
72. Ujiie M., Dickstein D.L., Carlow D.A., and Jefferies W.A. Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 10 (2003) 463-470
73. Kalaria R.N. Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease. Ann. N. Y. Acad. Sci. 826 (1997) 263-271